Breast cancer in arab populations: Molecular characteristics and disease management implications

The Lancet Oncology

Volumn 14, Issue 10, 2013, Pages

  Chouchane, Lotfi ^a   Boussen, Hammouda ^b   Sastry, Konduru S R ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (Qatar)

^b ABDERRAHMAN MAMI HOSPITAL   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; MICRORNA; PROGESTERONE RECEPTOR; TAXANE DERIVATIVE; TRASTUZUMAB;

ADJUVANT THERAPY; ADVANCED CANCER; AGE; ARAB; BREAST CANCER; BREAST CARCINOGENESIS; CANCER ADJUVANT THERAPY; CANCER GENETICS; CANCER GRADING; CANCER INCIDENCE; CANCER RESEARCH; CANCER RISK; CANCER SCREENING; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CLINICAL FEATURE; CONSANGUINITY; DISEASE COURSE; EARLY DIAGNOSIS; EGYPT; GENE EXPRESSION PROFILING; GENE MUTATION; GENE OVEREXPRESSION; GENETIC RISK; GENOME ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN GENOME; INFLAMMATORY BREAST CANCER; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; MASTECTOMY; METASTASIS POTENTIAL; MOLECULAR BIOLOGY; MOLECULAR GENETICS; POPULATION GENETICS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SAUDI ARABIA; SINGLE NUCLEOTIDE POLYMORPHISM; TRIPLE NEGATIVE BREAST CANCER; TUMOR SUPPRESSOR GENE;

ARABS; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INCIDENCE; LYMPHATIC METASTASIS; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RECEPTOR, ERBB-2; RISK FACTORS;

EID: 84883015169     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(13)70165-7     Document Type: Review

References (73)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127:2893-2917.
2. Kestler DP, Foster JS, Bruker CT, et al. ODAM expression inhibits human breast cancer tumorigenesis. Breast Cancer (Auckl) 2011, 5:73-85.
3. El Saghir NS, Khalil MK, Eid T, et al. Trends in epidemiology and management of breast cancer in developing Arab countries: a literature and registry analysis. Int J Surg 2007, 5:225-233.
4. Teebi AS, Teebi SA Genetic diversity among the Arabs. Community Genet 2005, 8:21-26.
5. Tadmouri GO The Arab world. Genetic disorders in the Arab world: United Arab Emirates 2004, vol 1. Centre for Arab Genomic Studies, Dubai, 2004. G.O. Tadmouri, A.M.T. Al, K.N. Al (Eds.).
6. El Saghir SN, Abulkhair O Epidemiology, prevention and management guidelines for breast cancer in Arab countries. Pan Arab J Oncol 2010, 3:12-18.
7. Abulkhair O, Saghir N, et al. Modification and implementation of NCCN guidelines on breast cancer in the Middle East and North Africa region. J Natl Compr Canc Netw 2010, 8:S-815.
8. Al-Madouj A, Ravichandran K, Al-Zahrani A Cancer incidence among Gulf Cooperation Council states: nationals, 2005 2010, Gulf Centre for Cancer Registration, Riyadh.
9. Boulos S, Gadallah M, Neguib S, et al. Breast screening in the emerging world: high prevalence of breast cancer in Cairo. Breast 2005, 14:340-346.
10. Zaanouni E, Ben Abdallah M, Bouchlaka A, et al. Preliminary results and analysis of feasibility of mammography breast cancer screening in women younger than 50 years in the l'Ariana state of Tunisia. Tunis Med 2009, 87:443-449.
11. Najjar H, Easson A Age at diagnosis of breast cancer in Arab nations. Int J Surg 2010, 8:448-452.
12. Howlader N, Noone AM, Krapcho M, et al. SEER cancer statistics review, 1975-2009 (vintage 2009 populations). November 2011 (updated Aug 20, 2012) (accessed April 29, 2013). http://seer.cancer.gov/csr/1975_2009_pops09/.
13. Mellon S, Gauthier J, Cichon M, Hammad A, Simon MS Knowledge, attitude, and beliefs of Arab-American women regarding inherited cancer risk. J Genet Couns 2013, 22:268-276.
14. Brown R, Kerr K, Haoudi A, Darzi A Tackling cancer burden in the Middle East: Qatar as an example. Lancet Oncol 2012, 13:e501-e508.
15. Fakhro AE, Fateha BE, al-Asheeri N, al-Ekri SA Breast cancer: patient characteristics and survival analysis at Salmaniya Medical Complex, Bahrain. East Mediterr Health J 1999, 5:430-439.
16. Missaoui N, Jaidene L, Abdelkrim SB, et al. Breast cancer in Tunisia: clinical and pathological findings. Asian Pac J Cancer Prev 2011, 12:169-172.
17. Al Tamini DM, Shawarby MA, Ahmed A, Hassan AK, Alodaini AO Protein expression profile and prevalence pattern of the molecular classes of breast cancer: a Saudi population based study. BMC Cancer 2010, 10:223.
18. Al-Kuraya K, Schramel P, Skeik Amr S, et al. Predominance of high grade pathway in breast cancer development of Middle East women. Mod Pathol 2005, 18:891-897.
19. Bujassoum SM, Gehani AA Epidemiology of breast cancer in Qatar 1999-2002. Qatar Med J 2004, 13:43-45.
20. Al-Moundhri M, Al-Bahrani B, Pervez I, et al. The outcome of treatment of breast cancer in a developing country: Oman. Breast 2004, 13:139-145.
21. El-Zaemey S, Nagi N, Fritschi L, Heyworth J Breast cancer among Yemeni women using the National Oncology Centre Registry 2004-2010. Cancer Epidemiol 2012, 36:249-253.
22. Ezzat AA, Ibrahim EM, Raja MA, Al-Sobhi S, Rostom A, Stuart RK Locally advanced breast cancer in Saudi Arabia: high frequency of stage III in a young population. Med Oncol 1999, 16:95-103.
23. Zidan J, Sikorsky, Basher W, Sharabi A, Friedman E, Steiner M Differences in pathological and clinical features of breast cancer in Arab as compared to Jewish women in Northern Israel. Int J Cancer 2012, 131:924-929.
24. Fourati A, Boussen H, El May MV, et al. Descriptive analysis of molecular subtypes in Tunisian breast cancer. Asia Pac J Clin Oncol 2012, published online Nov 26. 10.1111/ajco.12034.
25. El Fatemi H, Chahbouni S, Jayi S, et al. Luminal B tumors are the most frequent molecular subtype in breast cancer of North African women: an immunohistochemical profile study from Morocco. Diagn Pathol 2012, 7:170.
26. Shawarby MA, Al-Tamimi DM, Ahmed A Very low prevalence of epidermal growth factor receptor (EGFR) protein expression and gene amplification in Saudi breast cancer patients. Diagn Pathol 2011, 6:57.
27. Lê MG, Arriagada R, Contesso G, et al. Dermal lymphatic emboli in inflammatory and noninflammatory breast cancer: a French-Tunisian joint study in 337 patients. Clin Breast Cancer 2005, 6:439-445.
28. Anderson WF, Schairer C, Chen BE, Hance KW, Levine PH Epidemiology of inflammatory breast cancer (IBC). Breast Dis 2005-2006, 22:9-23.
29. Boussen H, Bouzaiene H, Ben Hassouna J, Gamoudi A, Benna F, Rahal K Inflammatory breast cancer in Tunisia: reassessment of incidence and clinicopathological features. Semin Oncol 2008, 35:17-24.
30. Maalej M, Hentati D, Messai T, et al. Breast cancer in Tunisia: clinical and epidemiological study. Bull Cancer 1999, 86:302-306.
31. Soliman AS, Banerjee M, Lo AC, et al. High proportion of inflammatory breast cancer in the population-based cancer registry of Gharbiah, Egypt. Breast J 2009, 15:432-434.
32. Vine PH, Pogo BG, Klouj A, et al. Increasing evidence for a human breast carcinoma virus with geographic differences. Cancer 2004, 101:721-726.
33. Boussen H, Bouzaiene H, Hassouna JB, et al. Inflammatory breast cancer in Tunisia: epidemiological and clinical trends. Cancer 2010, 116:2730-2735.
34. Lo AC, Kleer CG, Banerjee M, et al. Molecular epidemiologic features of inflammatory breast cancer: a comparison between Egyptian and US patients. Breast Cancer Res Treat 2008, 112:141-147.
35. Wu M, Wu ZF, Kumar-Sinha C, Chinnaiyan A, Merajver SD RhoC induces differential expression of genes involved in invasion and metastasis in MCF10A breast cells. Breast Cancer Res Treat 2004, 84:3-12.
36. Al-Foheidi M, Al-Mansour MM, Ibrahim EM Breast cancer screening: review of benefits and harms, and recommendations for developing and low-income countries. Med Oncol 2013, 30:471.
37. Kawar LN Barriers to breast cancer screening participation among Jordanian and Palestinian American women. Eur J Oncol Nurs 2012, 1:88-94.
38. Anderson BO, Cazap E, El Saghir NS, et al. Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010. Lancet Oncol 2011, 12:387-398.
39. Azaiza F, Cohen M Health beliefs and rates of breast cancer screening among Arab women. J Womens Health (Larchmt) 2006, 15:520-530.
40. Donnelly TT, Al-Khater A-H, Al-Kuwari M, et al. Study exploring breast cancer screening practices amongst Arabic women living in the state of Qatar. Avicenna 2011, 1. 10.5339/avi.2011.1.
41. Buzdar AV, Ibrahim NK, Francis D, et al. Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer. J Clin Oncol 2005, 23:3676-3685.
42. Easton DF, Pooley KA, Dunning AM, et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007, 447:1087-1093.
43. Hunter DJ, Kraft P, Jacob KB, et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 2007, 39:870-874.
44. Zhang B, Beeghly-Fadiel A, Long J, Zheng W Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. Lancet Oncol 2011, 12:477-488.
45. Rouba A, Kaisi N, Al-Chaty E, et al. Patterns of allelic loss at the BRCA1 locus in Arabic women with breast cancer. Int J Mol Med 2000, 6:565-569.
46. Troudi W, Uhrhammer N, Romdhane KB, et al. Complete mutation screening and haplotype characterization of BRCA1 gene in Tunisian patients with familial breast cancer. Cancer Biomark 2008, 4:11-18.
47. Mahfoudh W, Bouaouina N, Ahmed SB, et al. Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population. Mol Biol Rep 2012, 39:1037-1046.
48. Uhrhammer N, Abdelouahab A, Lafarge L, Feillel V, Ben Dib A, Bignon YJ BRCA1 mutations in Algerian breast cancer patients: high frequency in young, sporadic cases. Int J Med Sci 2008, 5:197-202.
49. Jalkh N, Nassar-Slaba J, Chouery E, et al. Prevalance of BRCA1 and BRCA2 mutations in familial breast cancer patients in Lebanon. Hered Cancer Clin Pract 2012, 10:7.
50. Denic S, Al-Gazali L BRCA1 and BRCA2 mutations in breast cancer patients from Saudi Arabia. Saudi Med J 2003, 24:696.
51. Kadouri L, Bercovich D, Elimelech A, et al. A novel BRCA-1 mutation in Arab kindred from east Jerusalem with breast and ovarian cancer. BMC Cancer 2007, 7:14.
52. El-Harith el-HA, Abdel-Hadi MS, Steinmann D, Dork T BRCA1 and BRCA2 mutations in breast cancer patients from Saudi Arabia. Saudi Med J 2002, 23:700-704.
53. Peng S, Bingjian L, Wenjing R, Zhu Y, Sheng H, Lai M Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies. Breast Cancer Res Treat 2011, 127:309-324.
54. Shan J, Mahfoudh W, Dsouza SP, et al. Genome-wide association studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians. Breast Cancer Res Treat 2012, 135:715-724.
55. Snoussi K, Mahfoudh W, Bouaouina N, Ahmed SB, Helal AN, Chouchane L Genetic variation in IL-8 associated with increased risk and poor prognosis of breast carcinoma. Hum Immunol 2006, 67:13-21.
56. Hamrita B, Ben Nasr H, Gabbouj S, Bouaouina N, Chouchane L, Chahed K Apolipoprotein A1 -75 G/A and +83 C/T polymorphisms: susceptibility and prognostic implications in breast cancer. Mol Biol Rep 2011, 38:1637-1643.
57. Alshatwi AA, Hasan TN, Shafi G, Alsaif MA, Al-Hazzani AA, Alsaif AA A single-nucleotide polymorphism in the TP53 and MDM-2 gene modifies breast cancer risk in an ethnic Arab population. Fundam Clin Pharmacol 2012, 26:438-443.
58. Alshatwi AA, Shaf G, Hasan TN, et al. Single nucleotide polymorphisms in the p21 and bcl2 cancer susceptibility genes and breast cancer risk in Saudi Arabia. Asian Pac J Cancer Prev 2011, 12:2607-2610.
59. Lajin B, Alhaj Sakur A, Ghabreau L, Alachkar A Association of polymorphisms in one-carbon metabolizing genes with breast cancer risk in Syrian women. Tumour Biol 2012, 33:1133-1139.
60. Bener A, Alali K Consanguineous marriages in the new developed country: Qatari population. J Biosoc Sci 2006, 38:239-246.
61. Gilani GM, Kamal S Risk factors for breast cancer in Pakistani women aged less than 45 years. Ann Hum Biol 2004, 31:398-407.
62. Bener A, Ayoubi HR, Ali Al, Al-Kubaisi A, Al Sulaiti H Does consanguinity lead to decreased incidence of breast cancer?. Cancer Epidemiol 2010, 34:413-418.
63. Denic S, Bener A, Sabri S, Khatib F, Milenkovic J Parental consanguinity and risk of breast cancer: a population-based case-control study. Med Sci Monit 2005, 11:415-419.
64. Perou CM, Jeffrey SS, van de Rijn M, et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci USA 1999, 96:9212-9217.
65. Perou CM, Sørlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature 2000, 406:747-752.
66. van't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415:530-536.
67. Bin Amer SM, Maqbool Z, Nirmal MS, et al. Gene expression profiling in women with breast cancer in a Saudi population. Saudi Med J 2008, 29:507-513.
68. Chalabi N, Bernard-Gallon DJ, Bignon YJ, et al. Comparative clinical and transcriptomal profiles of breast cancer between French and South Mediterranean patients show minor but significative biological differences. Cancer Genomics Proteomics 2008, 5:253-261.
69. Tormey DC, Waalkes TP, Snyder JJ, Simon RM Biological markers in breast carcinoma: III-clinical correlations with carcinoembryonic antigen. Cancer 1977, 39:2397-2404.
70. Roth C, Rack B, Muller V, Janni W, Pantel K, Schwarzenbach H Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Res 2010, 12:R90.
71. Alshatwi AA, Shafi G, Hasan TN, et al. Differential expression profile and genetic variants of microRNAs sequences in breast cancer patients. PLoS One 2012, 7:e30049.
72. Hafez MM, Hassan ZK, Zekri AR, et al. MicroRNAs and metastasis-related gene expression in Egyptian breast cancer patients. Asian Pac J Cancer Prev 2012, 13:591-598.
73. Becker SM, Al Halees Z, Molina C, Paterson RM Consanguinity and congenital heart disease in Saudi Arabia. Am J Med Genet 2001, 99:8-13.